ArticleInternational journal of medical sciences2026

SF3A2: a promising therapeutic target and predictive biomarker for immunotherapy in colorectal cancer.

Changjiang Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.